EP0955997A1 - Compositions for topical use containing polysaccharide sulphates - Google Patents

Compositions for topical use containing polysaccharide sulphates

Info

Publication number
EP0955997A1
EP0955997A1 EP19970950086 EP97950086A EP0955997A1 EP 0955997 A1 EP0955997 A1 EP 0955997A1 EP 19970950086 EP19970950086 EP 19970950086 EP 97950086 A EP97950086 A EP 97950086A EP 0955997 A1 EP0955997 A1 EP 0955997A1
Authority
EP
Grant status
Application
Patent type
Prior art keywords
characterised
compositions according
polysaccharide
sulphates
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19970950086
Other languages
German (de)
French (fr)
Inventor
Alberto Reiner
Giorgio Reiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Pharma Research APR SA
Original Assignee
Applied Pharma Research APR SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/02Cosmetics or similar toilet preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Abstract

New cosmetic or pharmaceutical compositions for topical use in the form of gels or creams are described. The compositions contain polysaccharide sulphates, preferably carrageenins, having an average molecular weight of from 60 000 to 180 000 Daltons, preferably from 70 000 to 160 000 Dalton.

Description

COMPOSITIONS FOR TOPICAL USE CONTAINING POLYSACCHARIDE SULPHATES

The present invention relates to a new polysaccharide sulphate having an average molecular weight of from 60 000 to 180 000 Daltons for use mainly in the field of cosmetics and pharmaceuticals.

Polysaccharide sulphates and in particular copolymer sulphates of (l-3)-D- galactose and (l-4)-3,6-anhydro-D-galactose or (l-4)-3,6- anhydro-L- galactose, generally known as carrageenins, carrageenans or carrageens (The Merck Index, 11th Edition), have already been known and used for a long time owing to their properties of increasing the viscosity of aqueous solutions and suspensions and for their role as stabilising agents in respect of such solutions and suspensions. Therefore, polysaccharide sulphates are generally used for the preparation of gels, lotions, pastes, creams and ointments for topical use, although they are often used in other fields, such as, for example, in the food industry, especially with regard to the stabilisation of suspensions and emulsions containing milk or its derivatives, or in the paint and dyestuff industry. Carrageenins, in particular, are polysaccharide sulphates of natural origin which are normally extracted from algae and mucilage and which are classified in accordance with their structural formula as kappa, kappa II, iota, lambda, mu, nu and theta carrageenins. The commercial carrageenins generally available on the market contain all the forms in variable percentages, although the kappa, iota and lambda forms generally predominate.

The literature describes numerous methods of extracting and purifying carrageenins, and also various examples of cosmetic and pharmaceutical compositions based on polysaccharide sulphates and, in particular, carrageenins. US patent No. 3,236,833 describes a process for the extraction of carrageenin from marine algae by using hydrogen peroxide, while US patent No. 4,443,486 describes a process for the depolymerisation of commercial carrageenins based on the use of an aqueous hydrogen peroxide solution at a temperature of 75°C. As evidenced in US patent No. 4,543,250, carrageenins which are generally used for the preparation of formulations for pharmaceutical or cosmetic use are characterised in that they have a molecular weight of generally from 250 000 to 500 000 Daltons. These formulations have typical viscosities of from 3000 to 20 000 mPas at ambient temperature, in the case of concentrations of the polysaccharide variable from 1.5 to 2 % by weight.

These viscosity values, in particular, are of substantial importance because they permit optimum "spreadability" of the formulation, thus increasing the permeability, through the epidermis, of the active ingredients optionally contained therein.

The above-mentioned US patent No. 4,543,250 of Henry J. Witt marked a turning-point of substantial importance as regards the already well established approach to the use of polysaccharide sulphates and more specifically carrageenins in the production of formulations for cosmetic use and, in particular, in the production of shampoos or lotions for hair treatment. That patent teaches the use of polysaccharides having an extremely low molecular weight which, owing to their reduced dimensions, permit a substantial increase in the speed of reaction with the proteins of the dermis and above all the hair (keratin), leading to a considerable improvement in the healing effect which confers a smooth, soft and shining appearance on the hair.

According to the teaching of Henry J. Witt, these results are achieved by using highly depolymerised polysaccharide sulphates having a molecular weight of from 15 000 to 10 000 Daltons so that a 1.5 % by weight aqueous solution thereof has a viscosity not greater than 5 mPas at 75°C. The technical problem which the present invention is to solve differs substantially from those forming the main objects of the above-mentioned US patent.

The aim of the present invention is to provide cosmetic or pharmaceutical compositions for topical use, in the form of gels or creams, which do not have the disadvantages which characterised and still characterise the formulations currently on the market containing polysaccharide sulphates having a high molecular weight. As already mentioned, the customary formulations in the form of gels or creams for topical use contain polysaccharide sulphates and/or carrageenins having a molecular weight of generally from 250 000 to 500 000 Daltons. However, this type of formulation has the disadvantage, which has still not been resolved satisfactorily, of creating on the epidermis a more or less rigid film which, in the majority of cases, renders the application thereof unpleasant and troublesome, causing preference to be given to the use of formulations having a lower viscosity, such as, for example, those of the already mentioned US patent No. 4,543,250. These latter formulations, owing to their lower viscosity and density, are more difficult for the epidermis to absorb, to the detriment of the cosmetic or therapeutic effect of the active ingredient contained therein. The aim of the present invention is therefore to provide new cosmetic and pharmaceutical compositions in the form of gels or creams containing polysaccharide sulphates and capable of carrying active ingredients, while avoiding both the formation of troublesome and excessively rigid films on the epidermis, and the difficulties of absorption and thus lesser therapeutic or cosmetic efficacy.

This surprising result is obtained by using polysaccharide sulphates, preferably carrageenins, having an average molecular weight of from 60 000 to 180 000 Daltons, preferably from 70 000 to 160 000 Daltons. The carrageenins and, more generally, the polysaccharide sulphates used in the implementation of the present invention are obtained by the depolymerisation of polysaccharide sulphates, preferably commercial carrageenins, having a higher molecular weight. For a more advantageous implementation of the invention, the starting polysaccharide sulphates must have an average molecular weight of from 400 000 to 1 000 000 Daltons, preferably from 500 000 to 700 000

Daltons.

Processes for depolymerising the polysaccharide sulphates are well known in the art and generally use hydrogen peroxide (see, for example, US patents No. 3,236,833 and No. 4,443,486) or alkalies.

The preferred concentrations of the suitably depolymerised polysaccharide sulphate for the implementation of the present invention may vary from 0.2 to

10 % by weight as a function of the desired final viscosity.

The gels and the creams according to the present invention may be prepared simply by soaking the depolymerised polysaccharide in an aqueous solution containing the active ingredients, and optionally also conventional excipients and adjuvants, at a temperature of from 40 to 60°C for a period of from 45 to

90 minutes.

As can be seen from the data compiled in Table 1, formulations are thus obtained which have a viscosity (generally from 3000 to 9000 mPas at a temperature of 25°C when the concentration of the polysaccharide sulphate is

1.5 % by weight) comparable to that of the formulations currently available on the market, and which are therefore also spreadable but free from the disadvantages mentioned above.

TABLE 1

As already mentioned, the formulations thus obtained have the ability to create surface layers which penetrate completely into the epidermis, avoiding the creation of a rigid and troublesome film thereon.

In contrast, the carrageenins having a low molecular weight described in US patent No. 4,543,250 could not be used for the purposes of the present invention. It has been found that formulations containing carrageenins having a molecular weight of 48 000 - 49 000 Daltons in concentrations of 1.5 and 2 % have, respectively, viscosities of 1000 and 5000 mPas, respectively, which values are too low to ensure perfectly and easily spreadable formulations and which thus preclude a priori the use of polysaccharide sulphates having a molecular weight of approximately 10 000 - 15 000 Daltons for this purpose. The formulations of the present invention are also colourless, clear and perfectly spreadable on the epidermis with rapid and complete penetration, leaving the skin with a pleasant soft, glowing and smooth feel. The polysaccharides according to the present invention can be used in association with other gelling substances, both of synthetic nature (such as carboxypolymethylcellulose or carboxymethylcellulose) and of natural origin, thus obtaining gel-form formulations that are especially continuous, uniform and consistent, without losing the characteristics mentioned above. The formulations according to the present invention therefore lend themselves well to various uses, both in the cosmetic field and the pharmaceutical field; they can be used as carriers for one or more active ingredients or can be used directly for their moisturising and toning power. In this connection, it is important to underline that, according to the present invention, it is also possible to obtain microsuspensions in the form of homogeneous and uniform gels even in cases where water-insoluble active ingredients are used, such as, for example, sucralphate and non-steroidal anti- inflammatory drugs, in the case of active ingredients for pharmaceutical use, and Centella asiatica or liposoluble vitamins in the case of active ingredients for cosmetic use.

For this particular embodiment of the invention it is, however, necessary for the active ingredient for introduction into the composition to be in the form of micronised particles having a diameter of less than 10 μ. The preparation of microsuspensions in the form of gels would be difficult if not impossible using carrageenins having a low molecular weight, such as, for example, those in US patent No. 4,543,250 because, in addition to the already- mentioned contra-indications, it would not be possible to obtain a density sufficient to maintain the microsuspension and therefore the active ingredient would precipitate. It is also important to note how the formulations of the present invention can be subjected to lyophilisation without any contra-indications. The following Examples are given purely by way of non-limiting illustration of the invention (the parts are to be understood as parts by weight). Example 1 - Day cream

- Stearyl alcohol (21 ) EO : 3 %

- Stearyl alcohol (2) EO : 3.5 %

- Cetylstearyl alcohol : 2.5 %

- Karit butter: 3 % - Octyldodecyl myristate: 7 %

- Transesterified glyceryl triiso stearate (6) EO: 2 %

- Dimethylpolysiloxane: 1 %

- Sterile water: q.s. 100

- Acrylates: 1 % - Low MW* polysaccharide sulphate (102 000 Da): 0.5 %

- Glycosamine glycans: 0.3 %

- Vitamin E acetate: 1 %

- Perfume: 0.25 % *MW = molecular weight Example 2 - Moisturising cream

- Glyceryl stearate: 10 %

- Cetylstearyl alcohol: 10 %

- Hydrolysed potassium palmital protein: 10 %

- Jojoba oil: 5 % - Non-hydrolysable olive oil: 4 %

- Dimethylpolysiloxane: 1 %

- Karit butter: 5 %

- Self-oxidising mixture: 0.05 %

- Sterile water: q.s. 100 - Sodium hyaluronate: 0.1 %

- Low MW polysaccharide sulphate (75 000 Da): 0.6 %

- Glycerol: 4 %

- Perfume: 0.25 %

Example 3 - Leg gel

- Glycerol: 30 %

- Propylene glycol 20 %

- Sodium hyaluronate 0.1 %

- Low MW polysaccharide sulphate (75 000 Da): 0.4 %

- Glycosamine glycans: 0.3 %

- Sterile water: q.s. 100

Example 4 - Moisturising gel

- Glycerol: 3 %

- Sodium hyaluronate: 3%

- Acrylates: 0.5 %

- Low MW polysaccharide sulphate (115 000 Da): 0.6 %

- Sterile water: q.s. 100

- Perfume: 0.25 %

Example 5 - Moisturising gel

- Low MW polysaccharide sulphate (75 000 Da): 1.5 %

- Sterile water: q.s. 100

- Optional addition of KC1

Example 6 - Suspension in the form of sucralphate gel

- Sucralphate: 20 %

- Low MW polysaccharide sulphate (162 000 Da): 0.4 %

- Sorbitol: 12 %

- Potassium sorbate: 0.2 %

- Aspartame: 0.1 %

- Pulvaroma: 1.4 % - Demineralised water: q.s. 100

These gels by themselves or with active ingredients in suspension or in solution together with other excipients give rise to crosslinked light patches keeping the active ingredients completely distributed. These patches can be used as such with bandages or in other manners.

Claims

I . Compositions for topical use in the form of gels or creams, characterised in that they contain polysaccharide sulphates having an average molecular weight of from 60 000 to 180 000 Daltons.
2. Compositions according to Claim 1, characterised in that the polysaccharide sulphates have an average molecular weight of from 70 000 to 160 000 Daltons.
3. Compositions according to Claim 1, characterised in that the polysaccharide sulphates are carrageenins.
4. Compositions according to Claim 1, characterised in that they contain at least one cosmetic or pharmaceutical active ingredient.
5. Compositions according to Claim 1, characterised in that the polysaccharide sulphates are obtained by the depolymerisation of polysaccharide sulphates having an average molecular weight of from 400 000 to 1 000 000 Daltons.
6. Compositions according to Claim 5, characterised in that the polysaccharide sulphates are obtained by the depolymerisation of polysaccharide sulphates having an average molecular weight of from 500 000 to 700 000 Daltons.
7. Compositions according to Claim 1, characterised in that the polysaccharide sulphates are present in a variable amount of from 0.2 to 10 % by weight.
8. Compositions according to Claim 1, characterised in that they exhibit a viscosity of from 3000 to 9000 mPas at a temperature of 25°C when the concentration of the polysaccharide sulphate is 1.5 % by weight.
9. Compositions according to Claim 8, characterised in that they exhibit a viscosity of from 3500 to 4300 mPas.
10. Compositions according to Claim 1, characterised in that they contain the conventional excipients and adjuvants.
I I . Compositions according to Claim 1, characterised in that they contain water-insoluble ingredients in the form of micronised particles.
12. Compositions according to Claim 11, characterised in that the micronised particles have a diameter of less than 10 μ.
13. Compositions according to Claims 11 and 12, characterised in that they are in the form of gelled microsuspensions.
14. Compositions according to Claim 1 in lyophilised form.
15. Use of polysaccharide sulphates having an average molecular weight of from 60 000 to 180 000 Daltons for the preparation of compositions for topical use in the form of gels or creams.
16. Use according to Claim 15, characterised in that the polysaccharide sulphates have an average molecular weight of from 70 000 to 160 000 Daltons.
17. Use of polysaccharide sulphates according to Claim 15 together with cosmetic and pharmaceutical active ingredients.
EP19970950086 1996-11-04 1997-10-29 Compositions for topical use containing polysaccharide sulphates Withdrawn EP0955997A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CH271996A CH690814A5 (en) 1996-11-04 1996-11-04 Compositions for topical use containing sulphates polysaccharides.
CH271996 1996-11-04
PCT/EP1997/006074 WO1998019663A1 (en) 1996-11-04 1997-10-29 Compositions for topical use containing polysaccharide sulphates

Publications (1)

Publication Number Publication Date
EP0955997A1 true true EP0955997A1 (en) 1999-11-17

Family

ID=4240068

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19970950086 Withdrawn EP0955997A1 (en) 1996-11-04 1997-10-29 Compositions for topical use containing polysaccharide sulphates

Country Status (2)

Country Link
EP (1) EP0955997A1 (en)
WO (1) WO1998019663A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1424081A4 (en) * 2001-08-10 2005-09-21 Toray Industries Polysaccharide-containing compositions and use thereof
FR2876581B1 (en) * 2004-10-20 2007-05-18 Interpharm Dev Bioadhesive composition PROGRAMMED LIBERATION
FR2895907B1 (en) * 2006-01-06 2012-06-01 Anteis Sa Viscoelastic gel has dermatological use
FR2957923B1 (en) * 2010-03-25 2013-06-28 Greentech New extract Halymenia durvillei, process for preparing such an extract and cosmetic use
FR3047173B1 (en) * 2016-01-29 2018-02-09 Soc Ind Limousine D'application Biologique Cosmetic agent comprising a galactomannan obtained from Caesalpinia spinosa and galactans sulfates obtained from Kappaphycus alvarezii

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543250A (en) * 1983-04-11 1985-09-24 Fmc Corporation Toiletry formulations comprising low molecular weight carrageenan
JPH0465047B2 (en) * 1986-12-15 1992-10-16 Kanebo Ltd
JP2594486B2 (en) * 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド Topical ocular pharmaceutical composition
FR2690450B1 (en) * 1992-04-27 2002-06-14 Coletica undecylenic acid derivatives with hydrophilic macromolecules and uses in cosmetics or in pharmacy.
EP0678030A1 (en) * 1993-01-08 1995-10-25 The Population Council Use of sulphated polysaccharides for preventing sexually transmitted diseases
JP3047058B2 (en) * 1993-10-26 2000-05-29 マルホ株式会社 During the sulfated polysaccharide containing oil-in-water emulsion composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9819663A1 *

Also Published As

Publication number Publication date Type
WO1998019663A1 (en) 1998-05-14 application

Similar Documents

Publication Publication Date Title
US4296130A (en) Methylsulfonylmethane and methods of use
US5300494A (en) Delivery systems for quaternary and related compounds
US5037803A (en) Product comprising a silicon organic compound combined with a cosmetically active substance
US5306498A (en) Cosmetic composition in the form of a triple emulsion
US4992476A (en) Skin cleansing and moisturizing composition and method of using and preparing same
US4999348A (en) Liquid crystal containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions
US4946870A (en) Delivery systems for pharmaceutical or therapeutic actives
US4992478A (en) Antiinflammatory skin moisturizing composition and method of preparing same
US6010706A (en) Container for ascorbic acid composition
US6319507B1 (en) Agar gel bead composition and method
US5961990A (en) Cosmetic particulate gel delivery system and method of preparing complex gel particles
US5002974A (en) Anesthetic/skin moisturizing composition and method of preparing same
JP2001342451A (en) Method for manufacturing thickener and cosmetic
WO1991002538A1 (en) Odor-masked and stabilized compositions for treating keratinous tissue, skin conditions, and promoting wound healing
US4992477A (en) Skin moisturizing composition and method of preparing same
US5935559A (en) Silicone composition containing a water-sensitive active agent
US20040052749A1 (en) Revitalising active complex for the skin
CN1813664A (en) Hydrogel beauty skin care paster and essence skin care liquid manufacturing process and product
EP0469232A1 (en) Materials for hair cosmetics and hair cosmetics
US20040180026A1 (en) Topical skin care composition
US4393045A (en) Cosmetic composition
WO2010143196A1 (en) Novel synergistic transparent / translucent hydrogel composition; method of preparing it and a sheet / film made thereform
JPH08268905A (en) Colloidal silk fibroin and composition containing the same
JPH0761915A (en) External agent for skin
US5965145A (en) Use of honey as keratolytic agent for improving the radiance and the complexion of the skin and treating wrinkles

Legal Events

Date Code Title Description
17P Request for examination filed

Effective date: 19990526

AK Designated contracting states:

Kind code of ref document: A1

Designated state(s): DE ES FR GB IT

17Q First examination report

Effective date: 20021206

18D Deemed to be withdrawn

Effective date: 20060530